EFFECT OF PH, INOCULUM SIZE, AND INCUBATION-TIME ON THE SUSCEPTIBILITY OF UREAPLASMA-UREALYTICUM TO ERYTHROMYCIN IN-VITRO

被引:23
作者
KENNY, GE
CARTWRIGHT, FD
机构
[1] Department of Pathobiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA
关键词
D O I
10.1093/clinids/17.Supplement_1.S215
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Determinations of the susceptibility of Ureaplasma urealyticum to erythromycin in vitro as measured by the broth dilution method have shown wide variations with minimal inhibitory concentrations (MICs) from 0.04 to greater-than-or-equal-to 8 mug/mL, indicating a need for standardization. The effects of pH, inoculum size, and incubation were studied. In the broth dilution test, pH had an important effect. The apparent MIC was 4- to 16-fold higher at pH 6.0 than at pH 7.0, with the MIC falling progressively from values of 8 to greater-than-or-equal-to 8 mug/mL to values of 0.25 to 1 mug/mL as the pH of the medium was increased in steps to pH 7.0. Large inocula also inflated the MICs 2- to 4-fold. In addition, the time of incubation influenced the apparent MIC, with increases of 4- to 16-fold between days 1 and 5. In agar dilution assays, MICs decreased from 2 mug/mL at pH 6.2 to 0.5 mug/mL at pH 6.6. Since pH, inoculum level, and incubation time appear to be responsible for most of the variation in results, we propose that susceptibility testing for ureaplasmas can be improved by using medium with a more neutral pH than that usually used (pH 6) and by standardizing the inoculum size and incubation period.
引用
收藏
页码:S215 / S218
页数:4
相关论文
共 17 条
  • [1] DULBECCO R, 1990, MICROBIOLOGY, P769
  • [2] A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ERYTHROMYCIN FOR THE TREATMENT OF UREAPLASMA-UREALYTICUM TO PREVENT PREMATURE DELIVERY
    ESCHENBACH, DA
    NUGENT, RP
    RAO, AV
    COTCH, MF
    GIBBS, RS
    LIPSCOMB, KA
    MARTIN, DH
    PASTOREK, JG
    RETTIG, PJ
    CAREY, JC
    REGAN, JA
    GEROMANOS, KL
    LEE, MLF
    POOLE, WK
    EDELMAN, R
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (03) : 734 - 742
  • [3] INCIDENCE OF TETRACYCLINE-RESISTANT STRAINS OF UREAPLASMA-UREALYTICUM
    EVANS, RT
    TAYLORROBINSON, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 (01) : 57 - 63
  • [4] FACTORS INFLUENCING THE INVITRO SENSITIVITY OF UREAPLASMA-UREALYTICUM TO TETRACYCLINES
    JALIL, N
    GILCHRIST, C
    TAYLORROBINSON, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (03) : 341 - 345
  • [5] INVITRO SUSCEPTIBILITY OF UREAPLASMA-UREALYTICUM CLINICAL ISOLATES TO NEW MACROLIDES
    KANAMOTO, Y
    MIYAKE, Y
    SUGINAKA, H
    USUI, T
    [J]. CHEMOTHERAPY, 1991, 37 (04) : 256 - 259
  • [6] SUSCEPTIBILITIES OF GENITAL MYCOPLASMAS TO THE NEWER QUINOLONES AS DETERMINED BY THE AGAR DILUTION METHOD
    KENNY, GE
    HOOTON, TM
    ROBERTS, MC
    CARTWRIGHT, FD
    HOYT, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) : 103 - 107
  • [7] SUSCEPTIBILITY OF MYCOPLASMA-PNEUMONIAE TO SEVERAL NEW QUINOLONES, TETRACYCLINE, AND ERYTHROMYCIN
    KENNY, GE
    CARTWRIGHT, FD
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) : 587 - 589
  • [8] AGAR DILUTION METHOD FOR DETERMINATION OF ANTIBIOTIC SUSCEPTIBILITY OF UREAPLASMA-UREALYTICUM
    KENNY, GE
    CARTWRIGHT, FD
    ROBERTS, MC
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1986, 5 (06) : S332 - S334
  • [9] Kenny GE, 1991, MANUAL CLIN MICROBIO, P478
  • [10] MECHANISMS OF MACROLIDE RESISTANCE IN UREAPLASMA-UREALYTICUM - A STUDY ON COLLECTION AND CLINICAL STRAINS
    PALU, G
    VALISENA, S
    BARILE, MF
    MELONI, GA
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1989, 5 (02) : 146 - 153